Radnet Inc
RDNTHealthcare·Diagnostics & Research·USA·Mid·NASD·Nov 11 • 3:59 PM ET
78.08+0.14 (0.18%)
2026-11-12 05:10 CET
Market cap
6,144.72 USD m
Revenue, TTM
2,384.32 USD m
Net income, TTM
-22.38 USD m
Free cash flow, TTM
115.05 USD m
EPS diluted, TTM
-0.29
P/E
-
Price
RDNT against its 20, 50 and 200-day averages2050200miss
9.0% under the 52-week high of 85.84 on 25 Nov 2025. 52-week low 50.82 on 17 Jun 2026. Last 15 sessions, 21.1% high to low
Volume 1.07× normal · the line is the 50-bar volume average
Profile
RDNT52-week range, 78% of the way up
50.8285.84
RadNet, Inc. engages in the provision of outpatient diagnostic imaging services in the United States. It operates through the following segments: Imaging Centers and Digital Health. The Imaging Centers segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. The Digital Health segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company was founded by Howard G. Berger in 1980 and is headquartered in Los Angeles, CA.
| Index | RUT |
|---|---|
| Employees | 8844 |
| IPO | Feb 27, 1991 |
| Beta | 1.39 |
| ATR, 14d | 3.26 |
| Rel volume | 1.07 |
| Short float | 12.59% |
| Insider own | 10.52% |
| Inst own | 103.65% |
Snapshot
6 groupsValuation
| Index | RUT |
|---|---|
| Market Cap | 6.15B |
| Enterprise Value | 7.89B |
| Income | -22.38M |
| Sales | 2.38B |
| Book/sh | 14.24 |
| Cash/sh | 9.53 |
| Dividend Est. | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Dividend Gr. 3/5Y | - - |
| Payout | - |
| Employees | 8844 |
| IPO | Feb 27, 1991 |
Ratios
| P/E | - |
|---|---|
| Forward P/E | 83.26 |
| PEG | 1.98 |
| P/S | 2.58 |
| P/B | 5.48 |
| P/C | 8.19 |
| P/FCF | 53.46 |
| EV/EBITDA | 27.20 |
| EV/Sales | 3.31 |
| Quick Ratio | 1.49 |
| Current Ratio | 1.49 |
| Debt/Eq | 1.94 |
| LT Debt/Eq | 1.85 |
| Option/Short | Yes / Yes |
Earnings
| EPS (ttm) | -0.29 |
|---|---|
| EPS next Y | 0.94 |
| EPS next Q | 0.26 |
| EPS this Y | 35.26% |
| EPS next Y | 77.77% |
| EPS next 5Y | 42.14% |
| EPS past 3/5Y | - 3.18% |
| Sales past 3/5Y | 12.57% 13.74% |
| EPS Y/Y TTM | -70.26% |
| Sales Y/Y TTM | 21.06% |
| EPS Q/Q | -25.14% |
| Sales Q/Q | 22.07% |
| Earnings | Nov 08 AMC |
| EPS/Sales Surpr. | 35.50% -0.27% |
Ownership
| Insider Own | 10.52% |
|---|---|
| Insider Trans | -0.62% |
| Inst Own | 103.65% |
| Inst Trans | 3.40% |
| ROA | -0.56% |
| ROE | -2.05% |
| ROIC | -0.70% |
| Gross Margin | 4.69% |
| Oper. Margin | 4.69% |
| Profit Margin | -0.94% |
| SMA20 | 6.49% |
| SMA50 | 7.35% |
| SMA200 | 19.53% |
| Trades | - |
Technical
| Shs Outstand | 78.77M |
|---|---|
| Shs Float | 70.49M |
| Short Float | 12.59% |
| Short Ratio | 12.94 |
| Short Interest | 8.88M |
| 52W High | 85.84 -9.04% |
| 52W Low | 50.82 53.64% |
| Volatility | 6.21% 4.11% |
| ATR (14) | 3.26 |
| RSI (14) | 61.73 |
| Beta | 1.39 |
| Rel Volume | 1.07 |
| Avg Volume | 685.85K |
| Volume | 731,112 |
Performance
| Perf Week | -2.72% |
|---|---|
| Perf Month | 9.19% |
| Perf Quarter | 1.00% |
| Perf Half Y | 47.38% |
| Perf YTD | 9.43% |
| Perf Year | -0.54% |
| Perf 3Y | 167.58% |
| Perf 5Y | 146.78% |
| Perf 10Y | 1048.24% |
| Recom | 1.11 |
| Target Price | 96.50 |
| Prev Close | 77.94 |
| Price | 78.08 |
| Change % | 0.18% |
Analyst ratings
latest 10 of 20| Date | Action | Analyst | Rating change | Target | Implied |
|---|---|---|---|---|---|
| Jan 09, 2026 | Initiated | KKeyBanc Capital Markets | Overweight | $92 | +17.8% |
| Jun 13, 2025 | Initiated | RB. Riley Securities | Buy | $69 | -11.6% |
| Mar 05, 2025 | Upgrade | RRaymond James | Outperform → Strong Buy | $85 → $65 | -16.8% |
| Sep 06, 2024 | Upgrade | BBarclays | Equal Weight → Overweight | $57 → $79 | +1.2% |
| Mar 06, 2024 | Initiated | BBarclays | Equal Weight | $48 | -38.5% |
| Aug 31, 2023 | Initiated | TTruist | Buy | $40 | -48.8% |
| Mar 31, 2023 | Initiated | CCJS Securities | Market Outperform | $30 | -61.6% |
| Mar 03, 2023 | Upgrade | RRaymond James | Mkt Perform → Outperform | $30 | -61.6% |
| Aug 12, 2021 | Initiated | BBarclays | Overweight | $39 | -50.1% |
| Mar 15, 2019 | Downgrade | RRaymond James | Strong Buy → Outperform | $16 → $17.50 | -77.6% |
Peers
Mkt cap| Ticker | Company | Mkt cap |
|---|---|---|
| DGX | Quest Diagnostics Inc | 28.46B |
| LH | Labcorp Holdings Inc | 30.23B |
| SGRY | Surgery Partners Inc | 3.49B |
| THC | Tenet Healthcare Corp | 23.32B |
| NEO | Neogenomics Inc | 2.18B |
| GEHC | GE HealthCare Technologies Inc | 37.35B |
| TEM | Tempus AI Inc | 14.49B |
| DVA | DaVita Inc | 11.54B |
| HCA | HCA Healthcare Inc | 105.71B |
| USPH | U.S. Physical Therapy Inc | 1.49B |
Insider trading
latest 14 of 25| Insider | Relationship | Date | Transaction | Cost | Shares | Value | Total held | Form |
|---|---|---|---|---|---|---|---|---|
| SWARTZ DAVID L | Director | Jun 18 '26 | Sale | 53.89 | 2,699 | 145,449 | 177,013 | Jun 22 04:15 PM |
| Wesdorp Cornelis | Pres & CEO, Digital Health | Jun 16 '26 | Sale | 58.11 | 4,750 | 276,022 | 69,075 | Jun 18 06:03 PM |
| DAVID SWARTZ | Director | Jun 18 '26 | Proposed Sale | 53.89 | 2,699 | 145,449 | Jun 18 05:30 PM | |
| Cornelis Wesdorp | Officer | Jun 16 '26 | Proposed Sale | 56.71 | 4,750 | 269,372 | Jun 16 04:41 PM | |
| Forthuber Stephen M | Pres & CEO-Eastern Operations | Jun 15 '26 | Sale | 58.16 | 44,067 | 2,562,911 | 507,199 | Jun 16 04:15 PM |
| STEPHEN M FORTHUBER | Officer | Jun 15 '26 | Proposed Sale | 58.16 | 44,067 | 2,562,818 | Jun 15 04:41 PM | |
| Berger Howard G | President, CEO | May 05 '26 | Option Exercise | 18.64 | 25,992 | 484,491 | 498,405 | May 06 06:21 PM |
| Sorensen Alma Gregory | Chief Strategy Officer | Mar 19 '26 | Sale | 62.20 | 15,000 | 933,014 | 1,208,923 | Mar 23 04:15 PM |
| ALMA GREGORY SORENSEN &KRISTII | Director | Mar 19 '26 | Proposed Sale | 62.20 | 15,000 | 933,006 | Mar 19 04:50 PM | |
| ALMA GREGORY SORENSEN | Director | Mar 16 '26 | Proposed Sale | 64.10 | 5,919 | 379,408 | Mar 18 07:42 PM | |
| Sorensen Alma Gregory | Chief Strategy Officer | Mar 18 '26 | Sale | 62.15 | 15,000 | 932,280 | 1,223,923 | Mar 18 07:38 PM |
| ALMA GREGORY SORENSEN &KRISTII | Director | Mar 18 '26 | Proposed Sale | 62.15 | 15,000 | 932,259 | Mar 18 04:22 PM | |
| Sorensen Alma Gregory | Chief Strategy Officer | Mar 10 '26 | Option Exercise | 0.00 | 62,964 | 0 | 1,244,842 | Mar 12 05:52 PM |
| STOLPER MARK | EVP, Chief Financial Officer | Dec 10 '25 | Option Exercise | 6.07 | 35,703 | 216,717 | 103,715 | Dec 12 04:15 PM |
Held by
AUM| Ticker | Company | AUM |
|---|---|---|
| IJR | iShares Core S&P Small-Cap ETF | AUM: 106.27B |
| VTI | Vanguard Morningstar Total Stock Market ETF | AUM: 687.42B |
| IWM | iShares Russell 2000 Index Fund | AUM: 77.38B |
| VB | Vanguard Morningstar Small-Cap ETF | AUM: 79.59B |
| QTUM | Defiance Quantum ETF | AUM: 4.80B |
| VBK | Vanguard Morningstar Small-Cap Growth ETF | AUM: 22.34B |
| VXF | Vanguard Extended Market Index ETF | AUM: 30.47B |
| IWO | iShares Russell 2000 Growth ETF | AUM: 14.06B |
| SPSM | State Street SPDR Portfolio S&P 600TM Small Cap ETF | AUM: 16.06B |
| DFAS | U.S. Small Cap Portfolio-ETF Class Shares | AUM: 15.51B |
News
latest 14 of 200- RadNet Beats On Adjusted EPS And Raises Imaging Outlook Again, But Digital Health Stalls And Needs A Steep Q4 (Earnings Whispers)
- RadNet: Q3 Earnings Snapshot (Associated Press)
- RadNet Reports Third Quarter Financial Results with Record Quarterly Revenue and Adjusted EBITDA(1) and Revises Upwards 2026 Financial Guidance Ranges (GlobeNewswire)
- RadNet's Fourth Straight Guidance Raise Hinges On Labor Costs And AI Revenue Ramp (Earnings Whispers)
- RadNet, Inc. Announces Date of its Third Quarter 2026 Financial Results Conference Call (GlobeNewswire)
- RadNet expands into teleradiology with $350M Onrad deal (MedTech Dive)
- RadNet acquires ONRAD in $355m deal to broaden radiology provision (Medical Device Network)
- RadNet, Inc. Announces Agreement to Acquire ONRAD, Inc. (GlobeNewswire)
- RadNet and WIN-NextGen Form a Collaboration to Inspire the Next Generation of Medical Imaging Professionals (GlobeNewswire)
- RadNet, Inc. to Present at the Morgan Stanley 24th Annual Global Healthcare Conference on Wednesday, September 16th, 2026 (GlobeNewswire)
- RadNet to Host Free Prostate Cancer Webinar on September 19, 2026 (GlobeNewswire)
- RadNet, Inc. to Present at the Jefferies Healthcare Services and Technology Conference on September 15, 2026 (GlobeNewswire)
- Nano-X Imaging (NNOX) Is 'One to Watch' (NewMediaWire)
- RadNet Inc (RDNT) (Q2 2026) Earnings Call Highlights: Record Revenue and AI-Driven Growth ... (GuruFocus.com) +6.76%
Quarterly earnings
actual against estimate| Period | Reported | EPS act | EPS est | EPS rep | Sales act | Sales est | Analysts |
|---|---|---|---|---|---|---|---|
| 2026Q3 | 2026-11-08 | 0.300 | 0.221 | 0.050 | 638.26 | 639.97 | 7 |
| 2026Q2 | 2026-08-09 | 0.290 | 0.201 | 0.096 | 622.72 | 610.87 | 7 |
| 2026Q1 | 2026-05-10 | -0.280 | -0.164 | -0.434 | 575.6 | 557.93 | 7 |
| 2025Q4 | 2026-03-02 | 0.230 | 0.204 | -0.008 | 547.71 | 516.69 | 7 |
| 2025Q3 | 2025-11-09 | 0.200 | 0.223 | 0.070 | 522.87 | 494.48 | 7 |
| 2025Q2 | 2025-08-10 | 0.310 | 0.157 | 0.191 | 498.23 | 489 | 6 |
| 2025Q1 | 2025-05-11 | -0.500 | -0.140 | -0.510 | 471.4 | 443.15 | 6 |
| 2024Q4 | 2025-02-27 | 0.070 | 0.220 | 0.071 | 477.1 | 461.8 | 4 |
| 2024Q3 | 2024-11-10 | 0.040 | 0.136 | 0.043 | 461.14 | 433.91 | 4 |
| 2024Q2 | 2024-08-07 | -0.040 | 0.169 | -0.041 | 459.71 | 438.53 | 4 |
| 2024Q1 | 2024-05-08 | -0.040 | 0.046 | -0.040 | 431.71 | 421.72 | 5 |
| 2023Q4 | 2024-02-29 | -0.030 | 0.140 | -0.027 | 420.38 | 410.11 | 4 |
| 2023Q3 | 2023-11-08 | 0.250 | 0.070 | 0.255 | 401.97 | 391.63 | 4 |
| 2023Q2 | 2023-08-08 | 0.120 | 0.073 | 0.137 | 403.72 | 389.29 | 4 |
| 2023Q1 | 2023-05-09 | -0.360 | -0.095 | -0.364 | 390.56 | 371.34 | 4 |
| 2022Q4 | 2023-02-28 | -0.020 | 0.117 | -0.016 | 383.88 | 347.27 | 3 |
Annual earnings
| Period | EPS act | EPS est | EPS rep | Sales act | Sales est |
|---|---|---|---|---|---|
| 2017FY | 0.000 | 0.270 | 0.001 | 922.19 | 915.1 |
| 2018FY | 0.660 | 0.247 | 0.662 | 975.15 | 966.14 |
| 2019FY | 0.290 | 0.260 | 0.294 | 1,154 | 1,148 |
| 2020FY | -0.290 | -0.220 | -0.292 | 1,072 | 1,065 |
| 2021FY | 0.460 | 0.713 | 0.463 | 1,315 | 1,330 |
| 2022FY | 0.170 | 0.260 | 0.173 | 1,430 | 1,393 |
| 2023FY | 0.050 | 0.320 | 0.047 | 1,617 | 1,606 |
| 2024FY | 0.040 | 0.493 | 0.037 | 1,830 | 1,814 |
| 2025FY | 0.390 | 0.377 | -0.250 | 2,040 | 2,009 |
| 2026FY | - | 0.528 | - | - | 2,514 |
| 2027FY | - | 0.938 | - | - | 2,868 |
| 2028FY | - | 1.120 | - | - | 3,124 |
Estimate revisions
last 14 periods| Period | Type | Date | Estimates | Up | Down | Mean | Low | High |
|---|---|---|---|---|---|---|---|---|
| 2026Q4 | S | 2026-11-10 | 7 | 2 | 1 | 676.05 | 670.31 | 686 |
| 2026Q4 | S | 2026-11-09 | 7 | 2 | 0 | 677.34 | 670.31 | 691 |
| 2026Q4 | S | 2026-11-08 | 7 | 0 | 1 | 670.63 | 654.4 | 691 |
| 2026Q4 | S | 2026-08-27 | 7 | 0 | 1 | 670.63 | 654.4 | 691 |
| 2026Q4 | S | 2026-08-11 | 7 | 0 | 0 | 671.93 | 654.4 | 691 |
| 2026Q4 | S | 2026-08-10 | 7 | 0 | 0 | 671.69 | 654.4 | 691 |
| 2026Q4 | S | 2026-08-05 | 7 | 0 | 0 | 670.72 | 652.22 | 689 |
| 2026Q4 | S | 2026-08-04 | 7 | 0 | 0 | 670.78 | 652.22 | 689.4 |
| 2026Q4 | S | 2026-08-01 | 7 | 0 | 0 | 671.32 | 652.22 | 693.2 |
| 2026Q4 | S | 2026-07-25 | 7 | 1 | 0 | 671.32 | 652.22 | 693.2 |
| 2026Q4 | S | 2026-06-09 | 7 | 3 | 0 | 671.32 | 652.22 | 693.2 |
| 2026Q4 | S | 2026-05-27 | 7 | 3 | 0 | 671.32 | 652.22 | 693.2 |
| 2026Q4 | S | 2026-05-18 | 7 | 3 | 0 | 671.32 | 652.22 | 693.2 |
| 2026Q4 | S | 2026-05-16 | 6 | 3 | 0 | 671.54 | 652.22 | 693.2 |
Estimate history
| EPS, annual | 0.001 | 0.662 | 0.294 | -0.292 | 0.463 | 0.173 | 0.047 | 0.037 | -0.248 | -0.294 |
|---|---|---|---|---|---|---|---|---|---|---|
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| EPS, quarterly | 0.043 | 0.071 | -0.51 | 0.191 | 0.07 | -0.008 | -0.434 | 0.096 | 0.052 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Sales, annual | 922.186 | 975.146 | 1154.179 | 1071.84 | 1315.077 | 1430.061 | 1616.63 | 1829.664 | 2040.21 | 2384.32 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM |
| Sales, quarterly | 461.142 | 477.101 | 471.399 | 498.23 | 522.869 | 547.712 | 575.631 | 622.72 | 638.257 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
| Shares, annual | 47.724 | 48.977 | 50.314 | 51.641 | 53.548 | 57.723 | 67.956 | 74.037 | 77.4 | 78.769 |
| Period | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | MRQ |
| Shares, quarterly | 73.976 | 74.037 | 74.957 | 75.067 | 77.032 | 77.4 | 78.546 | 78.647 | 78.769 | |
| Period | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
Income statement, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 2,384.32 | 2,040.21 | 1,829.66 | 1,616.63 | 1,430.06 | 1,315.08 | 1,071.84 | 1,154.18 | 975.15 |
| Cost of Goods Sold Incl. D&A | 2,272.57 | 1,949.41 | 1,718.39 | 1,523.63 | 1,380.22 | 1,219.97 | 1,052.70 | 1,080.30 | 940.45 |
| Gross Profit | 111.75 | 90.80 | 111.28 | 93.00 | 49.84 | 95.11 | 19.14 | 73.88 | 34.70 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 111.75 | 90.80 | 111.28 | 93.00 | 49.84 | 95.11 | 19.14 | 73.88 | 34.70 |
| Interest Expense | 80.28 | 77.84 | 92.97 | 64.48 | 50.84 | 48.83 | 45.88 | 48.04 | 43.46 |
| Unusual Expense | 37.37 | 26.38 | 24.88 | 17.11 | -37.94 | -4.32 | -19.26 | 0.85 | -33.67 |
| Net Income Before Taxes | 42.22 | 31.91 | 44.86 | 38.81 | 42.97 | 58.88 | -0.85 | 29.67 | 38.53 |
| Income Taxes | 17.68 | 14.86 | 6.03 | 8.47 | 9.36 | 14.56 | 0.90 | 6.23 | 0.39 |
| Consolidated Net Income | 24.53 | 17.05 | 38.84 | 30.34 | 33.61 | 44.32 | -1.75 | 23.44 | 38.13 |
| Net Income From Continuing Operations | -22.38 | -18.65 | 2.79 | 3.04 | 10.65 | 24.73 | -14.84 | 14.76 | 32.24 |
| Net Income | -22.38 | -18.65 | 2.79 | 3.04 | 10.65 | 24.73 | -14.84 | 14.76 | 32.24 |
| EPS (Recurring) | 0.05 | -0.00 | 0.27 | 0.23 | -0.29 | 0.41 | -0.56 | 0.31 | 0.18 |
| EPS (Basic, Before Extraordinaries) | -0.29 | -0.25 | 0.04 | 0.05 | 0.19 | 0.47 | -0.29 | 0.30 | 0.67 |
| EPS (Diluted) | -0.29 | -0.25 | 0.04 | 0.05 | 0.17 | 0.46 | -0.29 | 0.29 | 0.66 |
| EBITDA | 290.10 | 242.93 | 249.12 | 282.49 | 234.56 | 265.77 | 173.85 | 221.33 | 107.60 |
| Non-Operating Income (Expense) | 48.13 | 45.33 | 51.44 | 27.40 | 6.03 | 8.28 | 6.62 | 4.68 | 13.61 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 45.34 | 43.13 | 23.69 | 21.16 | 16.58 | 18.40 | 9.06 | 6.37 | 6.05 |
| Price To Earnings Ratio | - | - | - | 2,921.85 | 142.98 | 65.12 | - | 69.71 | 15.52 |
| Price To Sales Ratio | 2.29 | 2.63 | 2.85 | 1.39 | 0.75 | 1.22 | 0.93 | 0.88 | 0.51 |
| Gross Margin | 4.69 | 4.45 | 6.08 | 5.75 | 3.49 | 7.23 | 1.79 | 6.40 | 3.56 |
| Operating Margin | 4.69 | 4.45 | 6.08 | 5.75 | 3.49 | 7.23 | 1.79 | 6.40 | 3.56 |
| Net Margin | -0.94 | -0.91 | 0.15 | 0.19 | 0.74 | 1.88 | -1.38 | 1.28 | 3.31 |
| Shares Outstanding | 78.77 | 77.40 | 74.04 | 67.96 | 57.72 | 53.55 | 51.64 | 50.31 | 48.98 |
| Market Capitalization | 6,144.72 | 6,144.72 | 5,170.02 | 2,360.70 | 1,080.10 | 1,608.98 | 1,010.52 | 1,021.33 | 496.97 |
Income statement, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 | 2025Q1 | 2024Q4 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 638.26 | 622.72 | 575.63 | 547.71 | 522.87 | 498.23 | 471.40 | 477.10 |
| Cost of Goods Sold Incl. D&A | 596.68 | 573.57 | 592.02 | 510.30 | 488.04 | 462.78 | 488.29 | 447.45 |
| Gross Profit | 41.57 | 49.15 | -16.39 | 37.42 | 34.83 | 35.45 | -16.89 | 29.65 |
| Other Operating Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | 41.57 | 49.15 | -16.39 | 37.42 | 34.83 | 35.45 | -16.89 | 29.65 |
| Interest Expense | 20.68 | 18.15 | 17.66 | 23.79 | 17.57 | 18.21 | 18.27 | 22.96 |
| Unusual Expense | 17.02 | 8.78 | 7.68 | 3.89 | 8.77 | 4.81 | 8.91 | 6.54 |
| Net Income Before Taxes | 27.51 | 26.62 | -32.83 | 20.92 | 20.27 | 23.85 | -33.13 | 15.32 |
| Income Taxes | 8.36 | 6.36 | -8.10 | 11.05 | 6.38 | 0.82 | -3.40 | 1.10 |
| Consolidated Net Income | 19.15 | 20.25 | -24.73 | 9.86 | 13.89 | 23.03 | -29.74 | 14.22 |
| Net Income From Continuing Operations | 4.15 | 7.53 | -33.47 | -0.60 | 5.42 | 14.45 | -37.93 | 5.34 |
| Net Income | 4.15 | 7.53 | -33.47 | -0.60 | 5.42 | 14.45 | -37.93 | 5.34 |
| EPS (Recurring) | 0.20 | 0.17 | -0.36 | 0.03 | 0.15 | 0.24 | -0.43 | 0.13 |
| EPS (Basic, Before Extraordinaries) | 0.05 | 0.10 | -0.43 | -0.01 | 0.07 | 0.19 | -0.51 | 0.07 |
| EPS (Diluted) | 0.05 | 0.10 | -0.43 | -0.01 | 0.07 | 0.19 | -0.51 | 0.07 |
| EBITDA | 88.58 | 94.68 | 28.57 | 78.27 | 74.63 | 71.45 | 18.59 | 65.67 |
| Non-Operating Income (Expense) | 23.65 | 4.40 | 8.90 | 11.18 | 11.79 | 11.42 | 10.94 | 15.18 |
| Other After Tax Adjustments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Stock Option Compensation Expense | 7.91 | 8.33 | 22.53 | 6.58 | 7.14 | 6.91 | 22.53 | 6.69 |
| Price To Earnings Ratio | - | - | - | - | - | - | 1,520.49 | - |
| Price To Sales Ratio | 2.29 | 2.14 | 2.01 | 2.68 | 2.99 | 2.25 | 1.98 | 2.88 |
| Gross Margin | 6.51 | 7.89 | -2.85 | 6.83 | 6.66 | 7.12 | -3.58 | 6.21 |
| Operating Margin | 6.51 | 7.89 | -2.85 | 6.83 | 6.66 | 7.12 | -3.58 | 6.21 |
| Net Margin | 0.65 | 1.21 | -5.81 | -0.11 | 1.04 | 2.90 | -8.05 | 1.12 |
| Shares Outstanding | 78.77 | 78.65 | 78.55 | 77.40 | 77.03 | 75.07 | 74.96 | 74.04 |
| Market Capitalization | 6,144.72 | 4,849.37 | 4,337.74 | 5,514.11 | 5,861.78 | 4,269.96 | 3,681.35 | 5,170.02 |
Balance sheet, annual
| Metric | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY | 2017FY |
|---|---|---|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 767.22 | 740.02 | 342.57 | 127.83 | 134.61 | 102.02 | 40.16 | 10.39 | 51.32 |
| Short Term Receivables | 212.91 | 227.69 | 189.05 | 185.33 | 140.45 | 135.42 | 156.00 | 149.51 | 157.86 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 52.00 | 51.54 | 47.66 | 54.02 | 49.21 | 32.98 | 47.05 | 48.79 | 26.17 |
| Total Current Assets | 1,032.13 | 1,019.25 | 579.28 | 367.18 | 324.26 | 270.42 | 243.22 | 208.69 | 235.35 |
| Net Property, Plant & Equipment | 1,497.95 | 1,334.53 | 1,200.43 | 1,169.48 | 1,068.54 | 883.00 | 812.22 | 345.73 | 244.30 |
| Total Investments and Advances | 130.34 | 104.06 | 92.71 | 57.89 | 42.23 | 34.53 | 34.47 | 37.97 | 52.44 |
| Intangible Assets | 1,056.17 | 792.01 | 770.08 | 783.89 | 570.42 | 525.27 | 483.67 | 458.69 | 297.20 |
| Deferred Tax Assets | 248.97 | 210.47 | 196.22 | 216.32 | 210.55 | 216.62 | 193.18 | 74.38 | 67.54 |
| Other Assets | 41.97 | 36.84 | 47.98 | 55.45 | 38.17 | 38.75 | 38.86 | 26.75 | 8.84 |
| Total Assets | 4,007.53 | 3,497.16 | 2,886.69 | 2,650.22 | 2,254.17 | 1,968.60 | 1,805.62 | 1,152.20 | 905.66 |
| Short Term Debt Incl. Current Port. of LT Debt | 87.36 | 81.31 | 73.95 | 70.01 | 76.62 | 108.16 | 104.18 | 39.27 | 34.09 |
| Accounts Payable | 153.23 | 96.45 | 122.89 | 102.68 | 86.46 | 70.07 | 64.30 | 68.04 | 28.54 |
| Other Current Liabilities | 346.17 | 301.95 | 240.61 | 294.04 | 211.71 | 219.88 | 158.95 | 132.21 | 128.98 |
| Total Current Liabilities | 586.76 | 479.71 | 437.45 | 466.72 | 374.78 | 398.11 | 327.43 | 239.52 | 191.61 |
| Long Term Debt | 1,771.50 | 1,647.55 | 1,417.16 | 1,443.46 | 1,321.17 | 1,076.75 | 1,076.89 | 633.01 | 575.04 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 270.87 | 232.70 | 212.00 | 225.57 | 195.69 | 181.94 | 158.63 | 42.88 | 36.69 |
| Other Liabilities | 22.52 | 3.79 | 6.72 | 23.02 | 16.36 | 53.49 | 9.53 | 36.55 | 32.41 |
| Total Liabilities | 2,651.64 | 2,363.75 | 2,073.33 | 2,158.77 | 1,908.01 | 1,710.29 | 1,572.48 | 951.95 | 835.74 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,089.89 | 902.31 | 630.70 | 333.00 | 228.90 | 165.74 | 151.69 | 127.18 | 61.56 |
| Total Shareholders Equity | 1,089.89 | 902.31 | 630.70 | 333.00 | 228.90 | 165.74 | 151.69 | 127.18 | 61.56 |
| Accumulated Minority Interest | 266.00 | 231.10 | 182.66 | 158.46 | 117.25 | 92.56 | 81.45 | 73.07 | 8.37 |
| Total Equity | 1,355.89 | 1,133.41 | 813.36 | 491.45 | 346.16 | 258.30 | 233.14 | 200.25 | 69.92 |
| Total Liabilities & Stockholders Equity | 4,007.53 | 3,497.16 | 2,886.69 | 2,650.22 | 2,254.17 | 1,968.60 | 1,805.62 | 1,152.20 | 905.66 |
| Book Value Per Share | 14.08 | 12.19 | 9.28 | 5.77 | 4.27 | 3.21 | 3.01 | 2.60 | 1.29 |
| Tangible Book Value Per Share | 0.44 | 1.49 | -2.05 | -7.81 | -6.38 | -6.96 | -6.60 | -6.77 | -4.94 |
| Full-Time Employees | 8,844 | 8,546 | 7,872 | 9,067 | 8,973 | 8,327 | 6,165 | 6,445 | 6,072 |
| Price to Book Ratio | 5.49 | 5.77 | 3.81 | 3.45 | 7.04 | 6.10 | 6.73 | 3.92 | 7.29 |
| Return on Assets | -0.50 | 0.09 | 0.11 | 0.43 | 1.17 | -0.79 | 1.00 | 3.13 | 0.01 |
| Return on Equity | -1.87 | 0.36 | 0.63 | 3.79 | 12.53 | -9.35 | 10.58 | 34.17 | 0.10 |
| Return on Invested Capital | -0.65 | 0.11 | 0.15 | 0.60 | 1.60 | -1.19 | 1.20 | 4.24 | 0.01 |
| Quick Ratio | 1.76 | 2.12 | 1.32 | 0.79 | 0.87 | 0.68 | 0.74 | 0.87 | 1.23 |
| Current Ratio | 1.76 | 2.12 | 1.32 | 0.79 | 0.87 | 0.68 | 0.74 | 0.87 | 1.23 |
Cash flow, annual
| Metric | TTM | 2025FY | 2024FY | 2023FY | 2022FY | 2021FY | 2020FY | 2019FY | 2018FY |
|---|---|---|---|---|---|---|---|---|---|
| Net Income | 24.53 | 17.05 | 38.84 | 30.34 | 33.61 | 44.32 | -1.75 | 23.44 | 38.13 |
| Depreciation | 178.36 | 152.13 | 137.84 | 189.49 | 184.72 | 170.66 | 154.71 | 147.45 | 72.90 |
| Other Funds (Non Cash) | 143.30 | 139.40 | 112.84 | 41.30 | -13.22 | 26.64 | 25.20 | 11.28 | -12.63 |
| Funds from Operations | 346.19 | 308.57 | 289.51 | 267.19 | 218.47 | 261.45 | 177.54 | 178.28 | 91.47 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | 1.62 | -9.75 | -56.49 | -46.33 | -72.05 | -111.96 | 55.47 | -73.96 | 25.28 |
| Income Taxes Payable | 15.16 | 10.83 | 6.45 | - | - | - | - | - | - |
| Cash from Operating Activities | 347.81 | 298.82 | 233.02 | 220.86 | 146.42 | 149.49 | 233.02 | 104.32 | 116.75 |
| Capital Expenditures | -232.75 | -213.25 | -188.07 | -176.60 | -119.45 | -143.00 | -94.17 | -74.15 | -72.18 |
| Net Assets From Acquisitions | -382.67 | -133.42 | -43.66 | -10.92 | -129.96 | -77.69 | -31.27 | -27.15 | -73.39 |
| Sale of Fixed Assets and Businesses | 2.48 | 3.68 | 22.51 | 5.20 | 3.90 | 0.62 | 0.83 | 7.18 | 5.21 |
| Purchase or Sale of Investments | 0.00 | -4.15 | -1.50 | -14.04 | -1.44 | -1.44 | -1.64 | -0.11 | -4.20 |
| Purchase of Investments | 0.00 | -4.15 | -1.50 | -14.04 | -1.44 | -1.44 | -1.64 | -0.25 | -4.20 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.13 | - |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 11.38 | 5.67 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.79 | 0.25 |
| Cash from Investing Activities | -601.56 | -341.48 | -210.71 | -196.35 | -246.95 | -221.51 | -126.24 | -93.44 | -144.31 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 5.71 | 5.45 | 219.05 | 245.97 | 0.29 | 0.49 | 0.00 | 0.07 | 0.02 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 5.71 | 5.45 | 219.05 | 245.97 | 0.29 | 0.49 | 0.00 | 0.07 | 0.02 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 218.38 | 245.83 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | 210.87 | 71.22 | 165.33 | -43.99 | 94.25 | 93.54 | -42.84 | 21.91 | -11.90 |
| Change in Long Term Debt | 210.87 | 71.22 | 165.33 | -43.99 | 94.25 | 93.54 | -42.84 | 21.91 | -11.90 |
| Issuance of Long Term Debt | 248.94 | 99.00 | 863.76 | 0.00 | 148.00 | 844.67 | 254.92 | 358.34 | 204.30 |
| Reduction of Long Term Debt | -38.07 | -27.78 | -698.43 | -43.99 | -53.75 | -751.13 | -297.76 | -336.44 | -216.20 |
| Net Financing Active Other Cash Flow | -14.10 | -6.85 | -8.79 | -11.47 | -0.89 | 10.65 | -1.99 | -3.06 | -1.43 |
| Other Financing Activities Uses | -14.10 | -6.85 | -8.79 | -11.47 | -0.89 | -2.43 | -1.99 | -3.06 | -1.43 |
| Cash from Financing Activities | 202.48 | 69.82 | 375.59 | 190.51 | 93.65 | 104.67 | -44.82 | 18.93 | -13.31 |
| Exchange Rate Effect | -2.83 | 0.03 | -0.45 | -0.29 | 0.11 | -0.07 | -0.10 | -0.03 | -0.07 |
| Net Change in Cash | -54.11 | 27.20 | 397.45 | 214.74 | -6.77 | 32.59 | 61.85 | 29.78 | -40.93 |
| Free Cash Flow | 115.05 | 85.57 | 44.95 | 44.26 | 26.97 | 11.62 | 138.85 | 30.17 | 44.57 |
| Preferred Dividends (Cash Flow) | - | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Price to Free Cash Flow | 47.44 | 62.70 | 116.15 | 50.79 | 40.03 | 138.46 | 7.17 | 33.81 | 11.11 |
| Deferred Taxes & Investment Tax Credit | - | 0.00 | 0.00 | 6.06 | 13.36 | 19.83 | -0.61 | -3.89 | -6.93 |
Balance sheet, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Cash & Short Term Investments | 750.61 | 726.27 | 455.34 | 767.22 | 804.72 | 833.15 |
| Short Term Receivables | 254.49 | 248.71 | 220.12 | 212.91 | 222.91 | 212.95 |
| Inventories | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Current Assets | 63.34 | 60.78 | 65.31 | 52.00 | 50.15 | 48.28 |
| Total Current Assets | 1,068.44 | 1,035.76 | 740.77 | 1,032.13 | 1,077.78 | 1,094.38 |
| Net Property, Plant & Equipment | 1,659.88 | 1,639.13 | 1,623.03 | 1,497.95 | 1,455.83 | 1,407.44 |
| Total Investments and Advances | 131.51 | 135.02 | 131.41 | 130.34 | 129.13 | 125.80 |
| Intangible Assets | 1,372.05 | 1,367.82 | 1,348.18 | 1,056.17 | 952.44 | 842.59 |
| Deferred Tax Assets | - | - | - | 248.97 | 5.26 | - |
| Other Assets | 48.52 | 48.63 | 41.99 | 41.97 | 44.84 | 44.76 |
| Total Assets | 4,280.40 | 4,226.35 | 3,885.39 | 4,007.53 | 3,665.28 | 3,514.97 |
| Short Term Debt Incl. Current Port. of LT Debt | 103.71 | 101.56 | 93.10 | 87.36 | 85.79 | 85.02 |
| Accounts Payable | 500.75 | 488.49 | 454.60 | 422.03 | 419.21 | 406.69 |
| Other Current Liabilities | 112.18 | 107.78 | 87.94 | 77.38 | 69.92 | 54.50 |
| Total Current Liabilities | 716.64 | 697.82 | 635.63 | 586.76 | 574.91 | 546.21 |
| Long Term Debt | 2,070.23 | 2,082.48 | 1,841.26 | 1,771.50 | 1,761.82 | 1,756.03 |
| Provision for Risks Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax Liabilities | 46.46 | 39.01 | 34.15 | 270.87 | - | 21.44 |
| Other Liabilities | 10.19 | 12.99 | 21.63 | 22.52 | 14.59 | 12.02 |
| Total Liabilities | 2,843.52 | 2,832.30 | 2,532.68 | 2,651.64 | 2,351.32 | 2,335.70 |
| Non-Equity Reserves | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock - Carrying Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Common Equity | 1,121.30 | 1,096.09 | 1,080.55 | 1,089.89 | 1,058.54 | 932.31 |
| Total Shareholders Equity | 1,121.30 | 1,096.09 | 1,080.55 | 1,089.89 | 1,058.54 | 932.31 |
| Accumulated Minority Interest | 315.58 | 297.96 | 272.16 | 266.00 | 255.42 | 246.95 |
| Total Equity | 1,436.88 | 1,394.05 | 1,352.71 | 1,355.89 | 1,313.96 | 1,179.26 |
| Total Liabilities & Stockholders Equity | 4,280.40 | 4,226.35 | 3,885.39 | 4,007.53 | 3,665.28 | 3,514.97 |
| Book Value Per Share | 14.24 | 13.94 | 13.76 | 14.08 | 13.74 | 12.42 |
| Tangible Book Value Per Share | -3.18 | -3.45 | -3.41 | 0.44 | 1.38 | 1.20 |
| Full-Time Employees | - | - | - | 8,844 | - | - |
| Price to Book Ratio | 5.49 | 4.48 | 3.97 | 5.19 | 6.14 | 4.75 |
| Return on Assets | -0.56 | -0.55 | -0.39 | -0.50 | -0.37 | -0.44 |
| Return on Equity | -2.05 | -2.08 | -1.43 | -1.87 | -1.30 | -1.65 |
| Return on Invested Capital | 0.13 | 0.24 | -1.15 | -0.02 | 0.19 | 0.54 |
| Quick Ratio | 1.49 | 1.48 | 1.17 | 1.76 | 1.87 | 2.00 |
| Current Ratio | 1.49 | 1.48 | 1.17 | 1.76 | 1.87 | 2.00 |
Cash flow, quarterly
| Metric | 2026Q3 | 2026Q2 | 2026Q1 | 2025Q4 | 2025Q3 | 2025Q2 |
|---|---|---|---|---|---|---|
| Net Income | 19.15 | 20.25 | -24.73 | 9.86 | 13.89 | 23.03 |
| Depreciation | 47.01 | 45.53 | 44.97 | 40.85 | 39.80 | 35.99 |
| Other Funds (Non Cash) | 36.16 | 29.26 | 47.21 | 30.66 | 27.53 | 31.22 |
| Funds from Operations | 102.33 | 95.05 | 67.44 | 81.37 | 81.22 | 90.25 |
| Extraordinary Item | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Changes in Working Capital | -11.76 | -0.95 | 11.53 | 2.79 | -28.39 | 30.10 |
| Income Taxes Payable | 8.12 | 5.32 | -9.10 | 10.83 | 3.51 | -8.65 |
| Cash from Operating Activities | 90.57 | 94.10 | 78.97 | 84.16 | 52.83 | 120.35 |
| Capital Expenditures | -55.51 | -56.28 | -69.93 | -51.03 | -60.45 | -52.94 |
| Net Assets From Acquisitions | -0.00 | -11.56 | -304.15 | -66.96 | -34.48 | -28.19 |
| Sale of Fixed Assets and Businesses | 0.53 | 0.47 | 0.28 | 1.21 | 0.04 | 2.41 |
| Purchase or Sale of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 16.33 | -16.33 |
| Purchase of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 16.33 | -16.33 |
| Sale Or Maturity of Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Uses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Sources | 1.89 | 3.82 | 2.83 | 2.83 | 2.83 | 0.00 |
| Cash from Investing Activities | -53.09 | -63.55 | -370.97 | -113.94 | -75.72 | -95.06 |
| Cash Dividends Paid | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Dividends (Cash Flow) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Change in Capital Stock | 1.91 | 0.51 | 0.10 | 3.19 | 1.70 | 0.43 |
| Repurchase of Common Pref Stock | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Sale of Common Pref Stock | 1.91 | 0.51 | 0.10 | 3.19 | 1.70 | 0.43 |
| Proceedsfrom Stock Options | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Issuance or Reduction of Debt, Net | -8.11 | 241.24 | -15.21 | -7.05 | -7.02 | 92.01 |
| Change in Long Term Debt | -8.11 | 241.24 | -15.21 | -7.05 | -7.02 | 92.01 |
| Issuance of Long Term Debt | 0.00 | 248.94 | 0.00 | 0.00 | 0.00 | 99.00 |
| Reduction of Long Term Debt | -8.11 | -7.70 | -15.21 | -7.05 | -7.02 | -7.00 |
| Net Financing Active Other Cash Flow | -6.63 | -1.52 | -2.40 | -3.54 | 0.00 | -2.40 |
| Other Financing Activities Uses | -6.63 | -1.52 | -2.40 | -3.54 | 0.00 | -2.40 |
| Cash from Financing Activities | -12.84 | 240.22 | -17.50 | -7.39 | -5.32 | 90.04 |
| Exchange Rate Effect | -0.30 | 0.17 | -2.37 | -0.33 | -0.22 | 0.50 |
| Net Change in Cash | 24.34 | 270.93 | -311.88 | -37.50 | -28.44 | 115.83 |
| Free Cash Flow | 35.06 | 37.82 | 9.04 | 33.13 | -7.62 | 67.41 |
| Price to Free Cash Flow | 47.44 | 67.09 | 42.24 | 63.90 | 113.29 | 56.55 |
Revenue breakdown
| Capitation Arrangements | 2024: 136.58M 2025: 125.54M |
|---|---|
| Commercial Insurance | 2024: 1.02B 2025: 1.13B |
| Health Care, Management Service | 2024: 24.68M 2025: 27.52M |
| Health Care, Other | 2024: 46.72M 2025: 65.02M |
| Medicaid | 2024: 44.74M 2025: 51.74M |
| Medicare | 2024: 410.07M 2025: 476.99M |
| Other Payors | 2024: 104.89M 2025: 118.60M |
| Workers' Compensation/Personal Injury | 2024: 43.67M 2025: 44.70M |
| Non-US | 2024: 27.24M 2025: 33.97M |
| United States | 2024: 1.80B 2025: 2.01B |
| Digital Health | 2024: 37.35M 2025: 52.02M |
| Imaging Centers | 2024: 1.79B 2025: 1.99B |
Short interest
shares short against float, oldest to newest| Settlement | Of float | Shares short | Float | Avg volume |
|---|---|---|---|---|
| 2026-10-30 | 12.61% | 8.9M | 70.4M | 673.41K |
| 2026-10-15 | 12.87% | 9.1M | 70.4M | 693.93K |
| 2026-09-30 | 13.29% | 9.4M | 70.4M | 751.97K |
| 2026-09-15 | 13.73% | 9.7M | 70.4M | 836.82K |
| 2026-08-31 | 14.12% | 9.9M | 70.4M | 827.76K |
| 2026-08-14 | 13.75% | 9.7M | 70.4M | 831.39K |
| 2026-07-31 | 14.82% | 10.4M | 70.4M | 867.35K |
| 2026-07-15 | 14.27% | 10.0M | 70.4M | 912.51K |
| 2026-06-30 | 14.22% | 10.0M | 70.4M | 876.56K |
| 2026-06-15 | 12.53% | 8.8M | 70.4M | 806.04K |
| 2026-05-29 | 13.04% | 9.2M | 70.3M | 857.35K |
| 2026-05-15 | 12.87% | 9.1M | 70.3M | 904.39K |
| 2026-04-30 | 13.06% | 9.1M | 69.9M | 843.74K |
| 2026-04-15 | 12.70% | 8.8M | 69.4M | 802.51K |
| 2026-03-31 | 12.43% | 8.7M | 69.6M | 810.26K |
| 2026-03-13 | 11.93% | 8.3M | 69.6M | 875.17K |
| 2026-02-27 | 11.08% | 7.7M | 69.6M | 824.83K |
| 2026-02-13 | 11.15% | 7.7M | 69.4M | 840.21K |
| 2026-01-30 | 10.63% | 7.4M | 69.5M | 868.56K |
| 2026-01-15 | 10.76% | 7.5M | 69.4M | 871.47K |
Option chain
expiry 2026-11-20| Type | Strike | Bid | Ask | Last | IV | Open int | Volume | Delta | Theta | Vega |
|---|---|---|---|---|---|---|---|---|---|---|
| call | 40.00 | 36.40 | 40.10 | 0.00 | 3.867 | 0.00 | 0.00 | 0.969 | -0.130 | 0.009 |
| call | 45.00 | 31.30 | 35.10 | 0.00 | 3.265 | 0.00 | 0.00 | 0.963 | -0.127 | 0.010 |
| call | 50.00 | 26.40 | 30.10 | 0.00 | 2.775 | 0.00 | 0.00 | 0.956 | -0.123 | 0.011 |
| call | 55.00 | 21.60 | 25.10 | 25.00 | 2.286 | 42.00 | 0.00 | 0.947 | -0.118 | 0.013 |
| call | 60.00 | 16.60 | 20.20 | 10.94 | 1.943 | 30.00 | 0.00 | 0.934 | -0.111 | 0.016 |
| call | 65.00 | 11.70 | 15.20 | 15.25 | 1.510 | 88.00 | 0.00 | 0.916 | -0.103 | 0.019 |
| call | 70.00 | 7.20 | 9.80 | 9.35 | 1.010 | 45.00 | 1.00 | 0.876 | -0.097 | 0.025 |
| call | 75.00 | 3.80 | 4.40 | 4.20 | 0.530 | 383 | 19.00 | 0.696 | -0.141 | 0.042 |
| call | 80.00 | 1.05 | 2.00 | 1.76 | 0.577 | 86.00 | 14.00 | 0.407 | -0.148 | 0.047 |
| call | 85.00 | 0.05 | 0.65 | 0.55 | 0.565 | 80.00 | 1.00 | 0.191 | -0.111 | 0.033 |
| call | 90.00 | 0.00 | 2.25 | 0.20 | 0.793 | 20.00 | 0.00 | 0.140 | -0.122 | 0.027 |
| call | 95.00 | 0.00 | 2.15 | 0.00 | 0.992 | 0.00 | 0.00 | 0.117 | -0.135 | 0.024 |
| call | 100 | 0.00 | 2.15 | 0.00 | 1.170 | 0.00 | 0.00 | 0.103 | -0.145 | 0.022 |
| call | 105 | 0.00 | 2.15 | 0.00 | 1.333 | 0.00 | 0.00 | 0.093 | -0.154 | 0.020 |
| call | 110 | 0.00 | 2.15 | 0.00 | 1.483 | 0.00 | 0.00 | 0.086 | -0.161 | 0.019 |
| call | 115 | 0.00 | 2.15 | 0.10 | 1.059 | 6.00 | 0.00 | 0.012 | -0.023 | 0.004 |
| put | 40.00 | 0.00 | 2.10 | 0.05 | 2.597 | 10.00 | 0.00 | -0.031 | -0.126 | 0.009 |
| put | 45.00 | 0.00 | 2.10 | 0.05 | 2.198 | 1.00 | 0.00 | -0.037 | -0.122 | 0.010 |
| put | 50.00 | 0.00 | 2.10 | 0.41 | 1.838 | 1.00 | 0.00 | -0.044 | -0.117 | 0.011 |
| put | 55.00 | 0.00 | 2.15 | 0.00 | 1.508 | 1.00 | 0.00 | -0.053 | -0.112 | 0.013 |
| put | 60.00 | 0.00 | 0.60 | 0.40 | 1.199 | 97.00 | 0.00 | -0.066 | -0.105 | 0.016 |
| put | 65.00 | 0.05 | 0.45 | 0.10 | 0.907 | 180 | 8.00 | -0.084 | -0.096 | 0.019 |
| put | 70.00 | 0.15 | 0.50 | 0.35 | 0.641 | 142 | 69.00 | -0.124 | -0.089 | 0.025 |
| put | 75.00 | 0.75 | 1.45 | 1.00 | 0.578 | 217 | 65.00 | -0.304 | -0.133 | 0.042 |
| put | 80.00 | 2.90 | 5.00 | 3.60 | 0.483 | 38.00 | 11.00 | -0.593 | -0.139 | 0.047 |
| put | 85.00 | 5.90 | 8.80 | 7.49 | 0.910 | 12.00 | 0.00 | -0.809 | -0.102 | 0.033 |
| put | 90.00 | 10.10 | 13.60 | 0.00 | 1.133 | 0.00 | 0.00 | -0.860 | -0.112 | 0.027 |
| put | 95.00 | 15.00 | 18.70 | 0.00 | 1.395 | 0.00 | 0.00 | -0.883 | -0.125 | 0.024 |
| put | 100 | 20.00 | 23.70 | 0.00 | 1.606 | 0.00 | 0.00 | -0.897 | -0.134 | 0.022 |
| put | 105 | 25.00 | 28.70 | 0.00 | 1.798 | 0.00 | 0.00 | -0.907 | -0.142 | 0.020 |
| put | 110 | 30.00 | 33.70 | 0.00 | 1.974 | 0.00 | 0.00 | -0.914 | -0.148 | 0.019 |
| put | 115 | 35.00 | 38.50 | 0.00 | 2.068 | 0.00 | 0.00 | -0.988 | -0.010 | 0.004 |
Latest SEC filings
30| Filed | Form | Description | Period | Link |
|---|---|---|---|---|
| 2026-11-09 | 8-K | Current report | 2026-11-08 | SEC |
| 2026-11-09 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-09-30 | SEC |
| 2026-10-26 | 8-K | Current report | 2026-10-26 | SEC |
| 2026-08-14 | 8-K | Current report | 2026-08-14 | SEC |
| 2026-08-14 | 424B7 | SEC | ||
| 2026-08-14 | SCHEDULE 13G/A | SEC | ||
| 2026-08-10 | 8-K | Current report | 2026-08-09 | SEC |
| 2026-08-10 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-06-30 | SEC |
| 2026-06-22 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-18 | SEC |
| 2026-06-18 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-16 | SEC |
| 2026-06-18 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-16 | SEC |
| 2026-06-16 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-16 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-15 | SEC |
| 2026-06-15 | 144 | Filing for proposed sale of securities under Rule 144. | SEC | |
| 2026-06-10 | 8-K | Current report | 2026-06-10 | SEC |
| 2026-06-04 | 8-K | Current report | 2026-06-03 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-02 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-02 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-02 | SEC |
| 2026-06-03 | 4 | Statement of changes in beneficial ownership of securities | 2026-06-02 | SEC |
| 2026-06-03 | 8-K | Current report | 2026-06-03 | SEC |
| 2026-05-15 | SCHEDULE 13G | SEC | ||
| 2026-05-11 | 8-K | Current report | 2026-05-10 | SEC |
| 2026-05-11 | 10-Q | Quarterly report pursuant to Section 13 or 15(d) | 2026-03-31 | SEC |
| 2026-05-06 | 4 | Statement of changes in beneficial ownership of securities | 2026-05-05 | SEC |
| 2026-04-29 | SCHEDULE 13G | SEC | ||
| 2026-04-20 | ARS | Annual report to security holders. | 2025-12-31 | SEC |
| 2026-04-20 | DEFA14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | SEC | |
| 2026-04-20 | DEF 14A | Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 | 2026-06-02 | SEC |
Insider activity by month
| Month | Bought | Buys | Sold | Sells |
|---|---|---|---|---|
| 2026-11 | 0 | 0 | 0 | 0 |
| 2026-10 | 0 | 0 | 0 | 0 |
| 2026-09 | 0 | 0 | 0 | 0 |
| 2026-08 | 0 | 0 | 0 | 0 |
| 2026-07 | 0 | 0 | 0 | 0 |
| 2026-06 | 0 | 0 | 2.98M | 3 |
| 2026-05 | 0 | 0 | 0 | 0 |
| 2026-04 | 0 | 0 | 0 | 0 |
| 2026-03 | 0 | 0 | 1.87M | 2 |
| 2026-02 | 0 | 0 | 0 | 0 |
| 2026-01 | 0 | 0 | 0 | 0 |
| 2025-12 | 0 | 0 | 3.53M | 1 |
| 2025-11 | 0 | 0 | 3.90M | 3 |
Institutional holders
| Manager | % owned |
|---|---|
| BlackRock, Inc. | 13.94% |
| RTW INVESTMENTS, LP | 6.16% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 5.72% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5.17% |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.06% |
| BECK MACK & OLIVER LLC | 4.02% |
| STATE STREET CORP | 3.61% |
| GEODE CAPITAL MANAGEMENT, LLC | 2.34% |
| Invesco Ltd. | 2.09% |
| AMERICAN CENTURY COMPANIES INC | 2.06% |
Funds
| Fund | % owned |
|---|---|
| iShares Core S&P Small-Cap ETF | 4.47% |
| Floating Rate Income Fund | 3.83% |
| VANGUARD TOTAL STOCK MARKET INDEX FUND | 2.86% |
| iShares Russell 2000 ETF | 2.34% |
| T. Rowe Price Mid-Cap Value Fund, Inc. | 2.23% |
| VANGUARD SMALL-CAP INDEX FUND | 2.07% |
| Defiance Quantum ETF | 1.45% |
| BARON SMALL CAP FUND | 1.27% |
| Small Cap Growth Fund | 1.25% |
| VANGUARD SMALL-CAP GROWTH INDEX FUND | 1.19% |
OakChart. RDNT. Cached 15 minutes.